Human Molecular Genetics, 2001, Vol. 10, No. 17 1853-1858
© 2001 Oxford University Press
Domain homologues of dopamine ß-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders?
MRC Functional Genetics Unit, University of Oxford, Department of Human Anatomy and Genetics, South Parks Road, Oxford OX1 3QX, UK
One of the defining characteristics of neurodegenerative diseases, including Parkinson’s, Alzheimer’s and Huntington’s diseases, is abnormal accumulations of iron, specifically in affected areas. Following injection of iron in rat brains, a relatively selective lesion of dopamine neurons, similar to parkinsonism, occurs. These observations indicate that Fe(II)-mediated generation of free radical species, by the Fenton reaction, might contribute to the pathoetiology of these diseases. Iron is known to possess multiple roles in the biosynthesis of catecholamines in dopaminergic neurons. These include, as Fe(II), facilitating the production of dopamine from phenylalanine by tyrosine hydroxylase, and as heme, assisting the recycling of ascorbate by cytochrome b-561 required for the generation of norepinephrine from dopamine by dopamine ß-hydroxylase. In this study, it is demonstrated that a human and mouse gene product, stromal cell-derived receptor 2, is a homologue of cytochrome b-561 and duodenal cytochrome b, and is thus predicted to be active as a ferric reductase. Moreover, this protein also contains a domain homologous to the N-terminal regulatory region of dopamine ß-hydroxylase. These findings from sequence analysis lead to a prediction that stromal cell-derived receptor 2 is a catecholamine-regulated ferric reductase active in the brain. Dysfunction of cytochrome b-561 or stromal cell-derived receptor 2, therefore, might predispose individuals to abnormal accumulation of Fe(III) and/or generation of cytotoxic free radicals as a consequence of a rapid cycling between Fe(III) and Fe(II). The hypothesis that aberrant ferric reductase activities are involved in the progression of neurodegenerative diseases should open up new avenues of research, and possibly therapy, for these devastating diseases.
+ Tel: +44 1865 272175; Fax: +44 1865 272420; Email: chris.ponting@human-anatomy.oxford.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Preger, N. Tango, C. Marchand, S. D. Lemaire, D. Carbonera, M. Di Valentin, A. Costa, P. Pupillo, and P. Trost Auxin-Responsive Genes AIR12 Code for a New Family of Plasma Membrane b-Type Cytochromes Specific to Flowering Plants Plant Physiology, June 1, 2009; 150(2): 606 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mizutani, R. Sanuki, K. Kakimoto, S. Kojo, and S. Taketani Involvement of 101F6, a Homologue of Cytochrome b561, in the Reduction of Ferric Ions J. Biochem., December 1, 2007; 142(6): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakanishi, F. Takeuchi, and M. Tsubaki Histidine Cycle Mechanism for the Concerted Proton/Electron Transfer from Ascorbate to the Cytosolic Haem b Centre of Cytochrome b561: A Unique Machinery for the Biological Transmembrane Electron Transfer J. Biochem., November 1, 2007; 142(5): 553 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Iyer, V. Anantharaman, and L. Aravind The DOMON domains are involved in heme and sugar recognition Bioinformatics, October 15, 2007; 23(20): 2660 - 2664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al. Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy Cancer Res., July 1, 2007; 67(13): 6293 - 6303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Lehman, D. J. Schulz, A. B. Barron, L. Wraight, C. Hardison, S. Whitney, H. Takeuchi, R. K. Paul, and G. E. Robinson Division of labor in the honey bee (Apis mellifera): the role of tyramine {beta}-hydroxylase J. Exp. Biol., July 15, 2006; 209(14): 2774 - 2784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Takeuchi, H. Hori, and M. Tsubaki Selective Perturbation of the Intravesicular Heme Center of Cytochrome b561 by Cysteinyl Modification with 4,4'-Dithiodipyridine J. Biochem., December 1, 2005; 138(6): 751 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamane, S.-J. Lee, B.-D. Kim, R. Tao, and J. K. C. Rose A coupled yeast signal sequence trap and transient plant expression strategy to identify genes encoding secreted proteins from peach pistils J. Exp. Bot., August 1, 2005; 56(418): 2229 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Takeuchi, H. Hori, E. Obayashi, Y. Shiro, and M. Tsubaki Properties of Two Distinct Heme Centers of Cytochrome b561 from Bovine Chromaffin Vesicles Studied by EPR, Resonance Raman, and Ascorbate Reduction Assay J. Biochem., January 1, 2004; 135(1): 53 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Seike, F. Takeuchi, and M. Tsubaki Reversely-Oriented Cytochrome b561 in Reconstituted Vesicles Catalyzes Transmembrane Electron Transfer and Supports Extravesicular Dopamine {beta}-Hydroxylase Activity J. Biochem., December 1, 2003; 134(6): 859 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Goodstadt and C. P. Ponting Sequence variation and disease in the wake of the draft human genome Hum. Mol. Genet., October 1, 2001; 10(20): 2209 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Buckley, J Dean, and I R Mahy Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series Heart, July 1, 1999; 82(1): 105 - 108. [Abstract] [Full Text] [PDF]
|
|